Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
-
Di Zenzo, Giovanni
Molecular and Cell Biology Laboratory, Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy
-
Di Lullo, Giulia
Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
-
Corti, Davide
Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland - Humabs BioMed SA, Bellinzona, Switzerland
-
Calabresi, Valentina
Molecular and Cell Biology Laboratory, Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy
-
Sinistro, Anna
Molecular and Cell Biology Laboratory, Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy
-
Vanzetta, Fabrizia
Humabs BioMed SA, Bellinzona, Switzerland
-
Didona, Biagio
Dermatology Division, Rome, Italy
-
Cianchini, Giuseppe
Dermatology Division, IDI-IRCCS, Rome, Italy
-
Hertl, Michael
Department of Dermatology and Allergology, Philipps University, Marburg, Germany
-
Eming, Rudiger
Department of Dermatology and Allergology, Philipps University, Marburg, Germany
-
Amagai, Masayuki
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan
-
Ohyama, Bungo
Department of Dermatology, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
-
Hashimoto, Takashi
Department of Dermatology, Kurume University School of Medicine and Kurume University Institute of Cutaneous Cell Biology, Kurume, Japan
-
Sloostra, Jerry
Pepscan Presto, Lelystad, The Netherlands
-
Sallusto, Federica
Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland
-
Zambruno, Giovanna
Molecular and Cell Biology Laboratory, Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carattere Scientifico (IDI-IRCCS), Rome, Italy
-
Lanzavecchia, Antonio
Institute for Research in Biomedicine (IRB), Faculty of Biomedical Sciences, Università della Svizzera italiana, Switzerland - Institute of Microbiology, Eidgenössische Technische Hochschule (ETH), Zürich, Switzerland
Show more…
Published in:
- The journal of clinical investigation. - 2012, vol. 122, no. 10, p. 3781-3790
English
Pemphigus vulgaris (PV) is an autoimmune blistering disease of skin and mucous membranes caused by autoantibodies to the desmoglein (DSG) family proteins DSG3 and DSG1, leading to loss of keratinocyte cell adhesion. To learn more about pathogenic PV autoantibodies, we isolated 15 IgG antibodies specific for DSG3 from 2 PV patients. Three antibodies disrupted keratinocyte monolayers in vitro, and 2 were pathogenic in a passive transfer model in neonatal mice. The epitopes recognized by the pathogenic antibodies were mapped to the DSG3 extracellular 1 (EC1) and EC2 subdomains, regions involved in cis-adhesive interactions. Using a site-specific serological assay, we found that the cis-adhesive interface on EC1 recognized by the pathogenic antibody PVA224 is the primary target of the autoantibodies present in the serum of PV patients. The autoantibodies isolated used different heavy- and light-chain variable region genes and carried high levels of somatic mutations in complementary-determining regions, consistent with antigenic selection. Remarkably, binding to DSG3 was lost when somatic mutations were reverted to the germline sequence. These findings identify the cis- adhesive interface of DSG3 as the immunodominant region targeted by pathogenic antibodies in PV and indicate that autoreactivity relies on somatic mutations generated in the response to an antigen unrelated to DSG3.
-
Language
-
-
Classification
-
Medicine
-
License
-
License undefined
-
Identifiers
-
-
Persistent URL
-
https://n2t.net/ark:/12658/srd1319142
Statistics
Document views: 64
File downloads:
- DiZenzo_JCI_2012.pdf: 131